| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/2006 | CN1727344A Derivant of cephalosporin of amidinothioacetamide, preparation method and application |
| 02/01/2006 | CN1727340A Temozolomide 8-carboxylic ester, and combination |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1727337A Compound in 4,4-dibasic-3,4-dihydro-2(1H) quinazolone category |
| 02/01/2006 | CN1727332A Compound in category of aryl methylamino dithio formic ether, preparation method and application |
| 02/01/2006 | CN1727327A Derivative in hydroxy anthraquinones category and application |
| 02/01/2006 | CN1727325A Compound of butenafine hydrochloride, preparation method, and application as medication for restraining and killing fungus |
| 02/01/2006 | CN1727319A Device in category of substitution tricyclo-diterpene-orthodiphenol, preparation method and application |
| 02/01/2006 | CN1727015A Imipenem/cilastatin powder for injection, and transfusion preparation device of three chamber for dissolving dissolvants |
| 02/01/2006 | CN1726945A Solid dispersion of extractive of general flavone of Balsamiferou Blumea Herb |
| 02/01/2006 | CN1726930A Combination of effective parts for anti tumors, preparation and application |
| 02/01/2006 | CN1726924A Combination of medication of possessing synergistic reaction |
| 02/01/2006 | CN1726923A Combination of medication for treating cardiovascular diseases and cerebrovascular disease |
| 02/01/2006 | CN1726922A Usage of stigmastane-3,5,6-alcohol and derivative for preparing antiviral remedy, and new stigmastane-3,5,6-derivative of tri-alcohol |
| 02/01/2006 | CN1726921A Oral preparation of prostaglandin E1 |
| 02/01/2006 | CN1726920A Nose taking powder of prostaglandin E |
| 02/01/2006 | CN1726919A Oral disintegration tablet of cefixime |
| 02/01/2006 | CN1726918A Method for preparing Meloxicam freeze-dry powder |
| 02/01/2006 | CN1726917A Ganciclovir lactated ringer solution and preparation method |
| 02/01/2006 | CN1726916A Oral disintegration tablet for dropping blood sugar and preparation method |
| 02/01/2006 | CN1726915A Nasal cavity taken drug system and combination of naloxone hydrochloride and preparation method |
| 02/01/2006 | CN1726914A Slow release tablet of rotundine and production process |
| 02/01/2006 | CN1726913A Powder and injection preparation of ciprofloxacin hydrochloride, and preparing method |
| 02/01/2006 | CN1726912A Slow release capsule of compound metformin pyrrolidone and preparation method |
| 02/01/2006 | CN1726911A Controlled release preparation of huperizine |
| 02/01/2006 | CN1726910A Effervescence tablet of miconazole nitrate for vagina and preparation technique |
| 02/01/2006 | CN1726909A Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 02/01/2006 | CN1726908A Oral emulsion combination of 'Chuanhuning' |
| 02/01/2006 | CN1726907A Method of preparing medication for preventing and curing hyperlipoidemia by using flavones picking up from marc of blueberry |
| 02/01/2006 | CN1726906A Slowl released tablet of naftifurine oxalate and producing method |
| 02/01/2006 | CN1726905A Isosorbide mononitrate capsule and dry preparation method |
| 02/01/2006 | CN1726904A New usage of alkannin |
| 02/01/2006 | CN1726901A Eucalyptus extracts |
| 02/01/2006 | CN1726899A Zero order controlled releasing drug system and preparation system |
| 02/01/2006 | CN1239701C Humanised antibodies to epidermal growth factor receptor |
| 02/01/2006 | CN1239511C Novel pyrazine derivatives or salts thereof, containing the derives or the salts and intermediates for the preparation of both |
| 02/01/2006 | CN1239501C A thiazolidniedione derivative and its use as antidiabetic |
| 02/01/2006 | CN1239498C Substituted pyrrolidines as CCR-3 receptor antagonists |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239496C Respiratory syncytial virus replication inhibitors |
| 02/01/2006 | CN1239492C Medication containing 1,6-methylene-[10]-annulene-furan and steroid |
| 02/01/2006 | CN1239490C Method for preparing sitaipulan |
| 02/01/2006 | CN1239486C Acridine derivative and its application |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239482C Positive modulators for nicotinic receptor agonists |
| 02/01/2006 | CN1239479C Method for preparation of pharmaceutical-grade dithiocarbamate |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 02/01/2006 | CN1239472C HIV integrase inhibitors |
| 02/01/2006 | CN1239203C Hydrogel composition for transdermal drug delivery |
| 02/01/2006 | CN1239195C Compound flavone capsule and pellet prepn. method |
| 02/01/2006 | CN1239194C Chinese patent medicine for treating coronary heart disease and angina pectoris |
| 02/01/2006 | CN1239193C Chinese medicine for treating trigeminal neuralgia and its preparation method |
| 02/01/2006 | CN1239186C Soft hypolipidemic Jiaosuan capsule and its production process |
| 02/01/2006 | CN1239180C Medicine for treating piles |
| 02/01/2006 | CN1239176C Lamina ointment for quickly treating burn and preparation method thereof |
| 02/01/2006 | CN1239175C Medicinal composition for treating hyperosteogeny and protrusion of lumber intervertebral disc and its preparation |
| 02/01/2006 | CN1239174C Chinese medicine composition for treating lumbago and scelalgia and hyperosteogeny and its preparing method |
| 02/01/2006 | CN1239169C Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method |
| 02/01/2006 | CN1239168C Medicine for treating constipation and preparation method thereof |
| 02/01/2006 | CN1239167C Medicines for treating thyroma and hydatoncus |
| 02/01/2006 | CN1239165C Therapeutic agent for eye inflammatory disease containing roxithromycin |
| 02/01/2006 | CN1239164C Haw effective part and its extracting method and uses |
| 02/01/2006 | CN1239163C Medicine composition for treating cerebrovascular disease |
| 02/01/2006 | CN1239162C Pain killing medicine composition |
| 02/01/2006 | CN1239161C Method for treating dry eye disorders |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 02/01/2006 | CN1239159C Medicine composition for reducing blood fat |
| 02/01/2006 | CN1239158C 2-methyl-thieno-benzodiazepine formulation |
| 02/01/2006 | CN1239157C Preparations stimulating nail growth |
| 02/01/2006 | CN1239156C Oral Solution for preventing and treating acalcerosis and its prepn process |
| 02/01/2006 | CN1239155C Medicinal composition for treating ischemic cerebrovascular accident and preparation method |
| 02/01/2006 | CN1239154C 5-HT IA receptor subtype agonist |
| 02/01/2006 | CN1239153C Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
| 02/01/2006 | CN1239152C Therapeutic formulation for administering tolterodine with controlled release |
| 02/01/2006 | CN1239151C Tablets quickly disintegrating in oral cavity |
| 02/01/2006 | CN1239149C Pharmaceutical formulation having masked taste and method for production thereof |
| 01/31/2006 | USRE38963 for treating a migraine, disorders associated with inflammation, menstrual disorders, respiratory disorders, gastrointestinal afflications, skin disorders |
| 01/31/2006 | USRE38962 Diphenyl-triazole derivatives and their use as anti-gestative immuno-suppressant and anti-tumoral agents |
| 01/31/2006 | US6993229 Method of making spun optical fiber with low PMD |
| 01/31/2006 | US6992219 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; treatment of sleep disorders |
| 01/31/2006 | US6992218 Method for obtaining aqueous formulations of oxidation-sensitive active principles |
| 01/31/2006 | US6992215 Thiol-based NAALADase inhibitors |
| 01/31/2006 | US6992211 Crystalline form of phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 01/31/2006 | US6992198 Method for the preparation of citalopram |
| 01/31/2006 | US6992197 Lactone compound |
| 01/31/2006 | US6992194 suspending crystal strutured or amorphous lipitor in diluents comprising alcohols and/or water mixtures to cause conversion, then separating the diluents; monodispersity |
| 01/31/2006 | US6992193 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992191 Hydrogenation of precursors to thiazolidinedione antihyperglycemics |
| 01/31/2006 | US6992190 Hydroxamic acid derivatives as antibacterials |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992188 Nitrogen compounds such as 2,5,6-trimethyl-7-(1-propylbutyl)-4-(2,4,6-trimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidine, used as Corticotropin-releasing factor (CRF) antagonists |
| 01/31/2006 | US6992187 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 01/31/2006 | US6992183 Reacting a polysaccharide from fermentation with isopropanol in a highly saline aqueous solution, n-deacetylation followed by n-sulfation, and treating ammonium salt with an o-sulfating agent |
| 01/31/2006 | US6992169 Drug moiety linked to a carrier moiety comprising a homeobox peptide or a fragment or derivative thereof. |
| 01/31/2006 | US6992110 Subclass of non-tricyclics which inhibit the reuptake of norepinephrine equal to or more than serotonin; milnacipran |
| 01/31/2006 | US6992109 administering an analog of GABA(4-aminobutyric acid) for treating urogenital disorders |
| 01/31/2006 | US6992108 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 01/31/2006 | US6992107 (photodynamic therapy); branched alkyl and substituted benzyl ALA esters are precursors to in vitro porphyrin formation upon illumination; enhanced tumor selectivity, improved uptake, reduced pain sensation when administered; in vitro diagnosis kit |
| 01/31/2006 | US6992106 Anti-tumor composition |